Enari H
Department of Research & Development, Kyokuto Pharmaceutical Ind. Co., Ltd., 3333-26 Aza-Asayama, Kamitezuna, Takahagi-shi, Ibaraki 318-0004, Japan.
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi. 2001;12(1):39-46.
Many researchers paid attention to Bacteroides fragilis group chiefly for the past this 20 years. Most of B. fragilis groups encountered in clinical specimens possesses beta-lac- tamase. However recently, many researchers report that beta-lactamase-producing anaerobic Gram-negative bacilli except for B. fragilis groups are often encountered in clinical specimens. These strains belonging to Prevotella spp. or Fusobacterium spp. These organisms are often coexist with streptococci such as "S. milleri" group in specimens. Because these facts are very important in chemotherapy, such as beta-lactamase producers must be detected securely. For such a specimen, selective media that phenylethyl alcohol or gentamicin was added is not suitable. On the other hand, paromomycin vancomycin Brucella HK agar is suitable selective medium for not only these organisms but also for B. fragilis. Therefore, paromomycin vancomycin Brucella HK agar is recommended as the first choice of selective agar to use together with non-selective agar at present.
在过去的20年里,许多研究人员主要关注脆弱拟杆菌群。临床标本中遇到的大多数脆弱拟杆菌群都具有β-内酰胺酶。然而,最近许多研究人员报告说,临床标本中经常遇到除脆弱拟杆菌群之外的产β-内酰胺酶的厌氧革兰氏阴性杆菌。这些菌株属于普雷沃菌属或梭杆菌属。这些微生物在标本中常与诸如“米勒链球菌”群等链球菌共存。由于这些情况在化疗中非常重要,比如必须准确检测出产β-内酰胺酶的菌株。对于这样的标本,添加了苯乙醇或庆大霉素的选择性培养基并不合适。另一方面,巴龙霉素万古霉素布鲁氏血琼脂不仅对这些微生物而且对脆弱拟杆菌都是合适的选择性培养基。因此,目前推荐将巴龙霉素万古霉素布鲁氏血琼脂作为与非选择性琼脂一起使用的首选选择性琼脂。